Compare Research Peptides
Select 2 peptides to compare benefits, dosage, administration routes, mechanisms, and side effect profiles side by side.
Loading comparison tool…
Select 2 peptides to compare benefits, dosage, administration routes, mechanisms, and side effect profiles side by side.
Vilon Lys-Glu dipeptide | Pinealon EDR tripeptide | |
|---|---|---|
| Evidence Grade | CEvidenceGrade CPrimarily animal or in-vitro studies; limited human data | CEvidenceGrade CPrimarily animal or in-vitro studies; limited human data |
| Regulatory | Research OnlyResearch OnlyNo regulatory approval in any major jurisdiction; for research use only | Research OnlyResearch OnlyNo regulatory approval in any major jurisdiction; for research use only |
| Category | Khavinson Bioregulators | Khavinson Bioregulators |
| Key Benefits |
|
|
| Dosage | 10 mg mg | 10 mg mg |
| Frequency | Daily for 5-10 days per month | Daily for 10-20 days per month |
| Administration | SubcutaneousOral | SubcutaneousOral |
| Mechanism | Vilon is a Khavinson bioregulator consisting of two amino acids (Lys-Glu). It regulates thymus and immune system function, with anti-aging and geroprotective properties. | Pinealon is a Khavinson bioregulator for the brain and nervous system. It consists of three amino acids (Glu-Asp-Arg) and supports cognitive function and neuroprotection. |
| Side Effects / Risks | Not specified | Not specified |
| Research Status | Research compound | Research compound |
Lys-Glu dipeptide
Khavinson BioregulatorsDosage
10 mg mg, Daily for 5-10 days per month
Administration
Key Benefits
Research Status
Research compound
EDR tripeptide
Khavinson BioregulatorsDosage
10 mg mg, Daily for 10-20 days per month
Administration
Key Benefits
Research Status
Research compound